Erratum: Genome-Wide Analysis in Human Colorectal Cancer Cells Reveals Ischemia-Mediated Expression of Motility Genes via DNA Hypomethylation (PLoS ONE (2014) 9:7 (e103243)) DOI: 10.1371/journal.pone.0103243);Genome-wide analysis in human colorectal cancer cells reveals ischemia-mediated expression of motility genes via DNA hypomethylation

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Skowronki, Karolina ^a   Andrews, Joseph ^b   Rodenhiser, David I ^b   Coomber, Brenda L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL HYPOXIA; CELL MOTION; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HYPOGLYCEMIA; ISCHEMIA; METASTASIS; METASTASIS POTENTIAL; PROMOTER REGION; UPREGULATION; COLORECTAL TUMOR; GENETIC ASSOCIATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ISCHEMIA; PROMOTER REGIONS, GENETIC;

EID: 84905409191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103243     Document Type: Erratum

References (62)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
2. Raghunand N, Gatenby RA, Gillies RJ (2003) Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76 Spec No1: S11-22. (Pubitemid 39530312)
3. Avni R, Cohen B, Neeman M (2011) Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed 24: 569-581.
4. Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458.
5. Subarsky P, Hill RP (2003) The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20: 237-250. (Pubitemid 36513228)
6. Pakneshan P, Szyf M, Rabbani SA (2005) Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications. Curr Cancer Drug Targets 5: 471-488. (Pubitemid 41502560)
7. Horiuchi A, Hayashi T, Kikuchi N, Hayashi A, Fuseya C, et al. (2012) Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1alpha to a hypoxia-induced, methylation free hypoxia response element (HRE) of S100A4 gene. Int J Cancer.
8. Gronbaek K, Hother C, Jones PA (2007) Epigenetic changes in cancer. APMIS 115: 1039-1059. (Pubitemid 350179474)
9. Watt F, Molloy PL (1988) Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 2: 1136-1143.
10. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389. (Pubitemid 28269714)
11. Boyes J, Bird A (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64: 1123-1134. (Pubitemid 121001199)
12. Bestor T, Laudano A, Mattaliano R, Ingram V (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 203: 971-983.
13. Bestor TH (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395-2402.
14. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
15. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92. (Pubitemid 13154475)
16. Hoffmann MJ, Schulz WA (2005) Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83: 296-321. (Pubitemid 41297199)
17. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492. (Pubitemid 36444330)
18. Eden A, Gaudet F, Waghmare A, Jaenisch R (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300: 455. (Pubitemid 36444319)
19. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, et al. (2002) Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62: 6442-6446. (Pubitemid 35364103)
20. Laner T, Schulz WA, Engers R, Muller M, Florl AR (2005) Hypomethylation of the XIST gene promoter in prostate cancer. Oncol Res 15: 257-264. (Pubitemid 41415104)
21. Xiao J, Chen HS (2004) Biological functions of melanoma-associated antigens. World J Gastroenterol 10: 1849-1853. (Pubitemid 39029277)
22. Kim KH, Choi JS, Kim IJ, Ku JL, Park JG (2006) Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J Gastroenterol 12: 5651-5657.
23. Barrow C, Browning J, MacGregor D, Davis ID, Sturrock S, et al. (2006) Tumor antigen expression in melanoma varies according to antigen and stage. Clin Cancer Res 12: 764-771. (Pubitemid 43259856)
24. Yanagawa N, Tamura G, Oizumi H, Endoh M, Motoyama T (2011) MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer. Anticancer Res 31: 171-175.
25. Jung EJ, Kim MA, Lee HS, Yang HK, Lee YM, et al. (2005) Expression of family A melanoma antigen in human gastric carcinoma. Anticancer Res 25: 2105-2111. (Pubitemid 40904611)
26. Kanai Y, Hirohashi S (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28: 2434-2442. (Pubitemid 350238944)
27. Shahrzad S, Bertrand K, Minhas K, Coomber BL (2007) Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2: 119-125. (Pubitemid 351682006)
28. Skowronski K, Dubey S, Rodenhiser D, Coomber B (2010) Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics 5: 547-556.
29. Consortium (2003) The International HapMap Project. Nature 426: 789-796.
30. Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, et al. (2001) Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A 98: 2538-2543. (Pubitemid 32209517)
31. Roschke AV, Stover K, Tonon G, Schaffer AA, Kirsch IR (2002) Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 4: 19-31. (Pubitemid 34075887)
32. Snyder BN, Cho Y, Qian Y, Coad JE, Flynn DC, et al. (2011) AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes. Eur J Cell Biol 90: 376-389.
33. Andrews J, Kennette W, Pilon J, Hodgson A, Tuck AB, et al. (2010) Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PLoS One 5: e8665.
34. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, et al. (2000) Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242.
35. Suzuki S, Hayashi Y, Wang Y, Nakamura T, Morita Y, et al. (1998) Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut 43: 798-805. (Pubitemid 28539659)
36. Rabbani SA, Mazar AP (2001) The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin N Am 10: 393-415, x. (Pubitemid 32472537)
37. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80: 617-623. (Pubitemid 29047530)
38. Buchler P, Reber HA, Tomlinson JS, Hankinson O, Kallifatidis G, et al. (2009) Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia 11: 196-206.
39. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143. (Pubitemid 36278449)
40. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, et al. (2002) Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J Biol Chem 277: 41571-41579. (Pubitemid 35257461)
41. Kita Y, Mimori K, Tanaka F, Matsumoto T, Haraguchi N, et al. (2009) Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma. Eur J Surg Oncol 35: 52-58.
42. Kwon OH, Park JL, Kim M, Kim JH, Lee HC, et al. (2011) Aberrant upregulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun 406: 539-545.
43. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, et al. (1995) Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132-4139.
44. Kwon M, MacLeod TJ, Zhang Y, Waisman DM (2005) S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 10: 300-325. (Pubitemid 40543035)
45. Liu J, Li X, Dong GL, Zhang HW, Chen DL, et al. (2008) In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer 8: 261.
46. Phipps KD, Surette AP, O'Connell PA, Waisman DM (2011) Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res 71: 6676-6683.
47. Haque I, Mehta S, Majumder M, Dhar K, De A, et al. (2011) Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol Cancer 10: 8.
48. Fromigue O, Hamidouche Z, Vaudin P, Lecanda F, Patino A, et al. (2011) CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. J Bone Miner Res 26: 1533-1542.
49. Xie JJ, Xu LY, Xie YM, Du ZP, Feng CH, et al. (2011) Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells. Int J Mol Med 27: 429-434.
50. Klein R, Stiller S, Gashaw I (2012) Epidermal growth factor upregulates endometrial CYR61 expression via activation of the JAK2/STAT3 pathway. Reprod Fertil Dev 24: 482-489.
51. Shimozaki K, Namihira M, Nakashima K, Taga T (2005) Stage- and site-specific DNA demethylation during neural cell development from embryonic stem cells. J Neurochem 93: 432-439. (Pubitemid 40547500)
52. Herath NI, Boyd AW (2010) The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer 126: 2003-2011.
53. Eskandarpour M, Huang F, Reeves KA, Clark E, Hansson J (2009) Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer 124: 16-26.
54. Takeuchi T, Adachi Y, Nagayama T, Furihata M (2011) Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer. Int J Exp Pathol 92: 79-86.
55. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, et al. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 93: 7149-7153. (Pubitemid 26243517)
56. Draghici S, Khatri P, Eklund AC, Szallasi Z (2006) Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22: 101-109. (Pubitemid 43152029)
57. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, et al. (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687. (Pubitemid 34111374)
58. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48: 1159-1161. (Pubitemid 18075525)
59. Leone G, Teofili L, Voso MT, Lubbert M (2002) DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica 87: 1324-1341. (Pubitemid 36005306)
60. Gravina GL, Ranieri G, Muzi P, Marampon F, Mancini A, et al. (2013) Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Oncol Rep 29: 1189-1195.
61. Frigola J, Sole X, Paz MF, Moreno V, Esteller M, et al. (2005) Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 14: 319-326.
62. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, et al. (2006) Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A 103: 12457-12462. (Pubitemid 44267281)